CARA logo

Cara Therapeutics (CARA) Current Liabilities

Annual Current Liabilities

$25.59 M
+$2.13 M+9.10%

31 December 2023

CARA Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$10.04 M
-$3.86 M-27.78%

30 September 2024

CARA Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CARA Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.1%-56.1%
3 y3 years+38.5%-35.4%
5 y5 years-36.7%-79.2%

CARA Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+45.3%-64.4%at low
5 y5 years-40.3%+45.3%-79.2%at low
alltimeall time-40.3%+1417.9%-79.2%+495.4%

Cara Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$10.04 M(-27.8%)
June 2024
-
$13.90 M(-7.9%)
Mar 2024
-
$15.10 M(-41.0%)
Dec 2023
$25.59 M(+9.1%)
$25.59 M(+11.8%)
Sept 2023
-
$22.88 M(-10.1%)
June 2023
-
$25.46 M(+52.6%)
Mar 2023
-
$16.68 M(-28.9%)
Dec 2022
$23.46 M(+33.2%)
$23.46 M(-16.8%)
Sept 2022
-
$28.19 M(+33.2%)
June 2022
-
$21.17 M(+15.7%)
Mar 2022
-
$18.30 M(+3.9%)
Dec 2021
$17.62 M(-4.7%)
$17.62 M(+13.4%)
Sept 2021
-
$15.53 M(+2.4%)
June 2021
-
$15.17 M(-8.2%)
Mar 2021
-
$16.52 M(-10.6%)
Dec 2020
$18.48 M(-56.9%)
$18.48 M(+11.4%)
Sept 2020
-
$16.60 M(-32.9%)
June 2020
-
$24.73 M(-24.2%)
Mar 2020
-
$32.60 M(-24.0%)
Dec 2019
$42.89 M(+6.0%)
$42.89 M(-11.2%)
Sept 2019
-
$48.30 M(+20.3%)
June 2019
-
$40.16 M(-5.3%)
Mar 2019
-
$42.41 M(+4.8%)
DateAnnualQuarterly
Dec 2018
$40.45 M(+375.5%)
$40.45 M(-6.5%)
Sept 2018
-
$43.24 M(+24.2%)
June 2018
-
$34.82 M(+406.5%)
Mar 2018
-
$6.88 M(-19.2%)
Dec 2017
$8.51 M(-26.2%)
$8.51 M(+17.0%)
Sept 2017
-
$7.27 M(+1.1%)
June 2017
-
$7.19 M(-42.5%)
Mar 2017
-
$12.51 M(+8.5%)
Dec 2016
$11.53 M(+118.9%)
$11.53 M(+69.0%)
Sept 2016
-
$6.83 M(-16.4%)
June 2016
-
$8.17 M(+34.1%)
Mar 2016
-
$6.09 M(+15.6%)
Dec 2015
$5.27 M(+55.0%)
$5.27 M(+56.1%)
Sept 2015
-
$3.37 M(+4.2%)
June 2015
-
$3.24 M(-5.5%)
Mar 2015
-
$3.43 M(+0.9%)
Dec 2014
$3.40 M(-37.5%)
$3.40 M(-44.2%)
Sept 2014
-
$6.09 M(+8.5%)
June 2014
-
$5.62 M(-2.4%)
Mar 2014
-
$5.75 M(+5.9%)
Dec 2013
$5.43 M(+222.2%)
$5.43 M(-25.3%)
Sept 2013
-
$7.28 M(+331.5%)
Dec 2012
$1.69 M(-42.4%)
$1.69 M
Dec 2011
$2.93 M
-

FAQ

  • What is Cara Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Cara Therapeutics?
  • What is Cara Therapeutics annual current liabilities year-on-year change?
  • What is Cara Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Cara Therapeutics?
  • What is Cara Therapeutics quarterly current liabilities year-on-year change?

What is Cara Therapeutics annual total current liabilities?

The current annual current liabilities of CARA is $25.59 M

What is the all time high annual current liabilities for Cara Therapeutics?

Cara Therapeutics all-time high annual total current liabilities is $42.89 M

What is Cara Therapeutics annual current liabilities year-on-year change?

Over the past year, CARA annual total current liabilities has changed by +$2.13 M (+9.10%)

What is Cara Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of CARA is $10.04 M

What is the all time high quarterly current liabilities for Cara Therapeutics?

Cara Therapeutics all-time high quarterly total current liabilities is $48.30 M

What is Cara Therapeutics quarterly current liabilities year-on-year change?

Over the past year, CARA quarterly total current liabilities has changed by -$12.84 M (-56.13%)